[MRI can be prescribed in patients with implanted cardiac devices (pacemaker, defibrillator) to optimize radiotherapy planning].
Une IRM peut être prescrite en situation de dispositif cardiaque implantable (pacemaker, défibrillateur), application à la radiothérapie.
Cardiovascular implantable electronic device
Contraindication
Contre-indication
Defibrillator
Dispositif cardiaque implantable
Défibrillateur
Imagerie
Imaging
Magnetic resonance imaging MRI
Pacemaker
Procedure
Procédure
Radiation therapy
Radiothérapie
Résonance magnétique IRM
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
27
10
2019
revised:
14
12
2019
accepted:
18
12
2019
pubmed:
24
5
2020
medline:
26
6
2020
entrez:
24
5
2020
Statut:
ppublish
Résumé
MRI is sometimes critical to optimal radiotherapy planning but may be contraindicated in increasing numbers of patients who carry an implantable cardiac device (ICD, pacemaker or defibrillator). This literature search reviews studies of MRI in DCI patients, morbidity and procedures for the different types of ICD. Several retrospective studies and two recent large prospective studies have shown that the use of an ICD is not an absolute contraindication to MRI, given that specific DCI monitoring is performed under the tridisciplinary supervision of the oncologist, radiologist and cardiologist for MRI≤1.5T. The rate of major complications is less than 5% unless probe replacement is performed. When it can be anticipated, new MRI-compatible ICD can be implanted rather than conventional ICD, but probe replacement is not currently recommended. Data for MRI beyond 1.5T and in case of MRI repeatability in the context of MRI-Linac treatments are lacking. MRI may be performed in ICD patients, as the risk of morbidity is very low; provided that tridisciplinary evaluation is performed.
Identifiants
pubmed: 32444285
pii: S1278-3218(20)30042-1
doi: 10.1016/j.canrad.2019.12.001
pii:
doi:
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
340-344Informations de copyright
Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.